Gary R. Maharaj

President and Chief Executive Officer at Surmodics Inc

Board

Since December 2010

Age

61 years

Tenure

Joined Surmodics, Inc. in December 2010 as President and Chief Executive Officer and was appointed to the Board of Directors at that time.

Also at Surmodics Inc

CWO

Charles W. Olson

Senior Vice President and President, Medical Device Coatings

GSW

Gordon S. Weber

Senior Vice President of Legal, General Counsel, Secretary

JJS

Joseph J. Stich

Senior Vice President of HR and President, In Vitro Diagnostics

About

Gary R. Maharaj has been the driving force behind Surmodics, Inc. since December 2010, when he joined the company as President and Chief Executive Officer and was simultaneously appointed to its Board of Directors. His leadership has steered the company towards innovative medical device solutions, specifically focusing on proprietary surface modification and drug-delivery coating technologies that improve the detection and treatment of disease.

Prior to his tenure at Surmodics, he held significant leadership roles in the medical device industry. He served as President and CEO of Arizant Inc. from 2006 to 2010, and before that, he held senior-level management roles at Augustine Medical, Inc. as well as various management and research positions at Smith & Nephew, PLC. With over 35 years of experience in the field, his extensive background spans marketing, research and development, and executive leadership.

While specific details regarding his personal background and education are not available, his professional journey highlights a well-established commitment to innovation and excellence in the medical device sector. His career progression and focus on addressing unmet clinical needs underscore a deep expertise and passion that continues to drive advancements at Surmodics.

$SRDX Performance Under Gary R. Maharaj

Past Roles

Organization	Role	Date Range	Details
Arizant Inc.	President and Chief Executive Officer	2006 to 2010	Provider of patient temperature management systems used in hospital operating rooms.
Augustine Medical, Inc.	Vice President of Marketing; Vice President of Research and Development	1996 to 2006	Predecessor to Arizant Inc.
Smith & Nephew, PLC	Various management and research positions	N/A	Worked in the orthopedic implant and rehabilitation divisions; global leader in advanced surgical devices and wound care products.

Fixed Compensation

Data from FY 2024

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$647,481	Annual	Fixed base salary for fiscal year 2024.
All Other Compensation	$13,800	Annual	Includes 401(k) matching contributions and amounts received under other benefit plans available to all employees.

Performance Compensation

Data from FY 2024

Non-Equity Incentive Plan Compensation

Metric (US$ millions)	Value
Threshold	$115.1M
Target	$121.1M
Maximum	$130.2M
Actual Performance	$126.1M
Achievement	127%

Strategic Objectives (Weight: 40% )

Achievement details: Preside hydrophilic coating studies: 150% , Pounce venous thrombectomy system: 100% , Pounce LP arterial thrombectomy system: 150% , Sublime microcatheter launch: 100%
Overall Strategic Achievement: 125%

Overall Weighting: Corporate Financial Objective: 60% , Strategic Objectives: 40%

Payout Details

Payout Component	Percentage of Base Salary	Amount
Target Incentive Opportunity	80%	$516,000
Actual Payout	N/A	$654,215

Evaluation & Vesting:

Evaluation Period: Fiscal Year 2024
Vesting: Immediate payout upon determination of performance results

Target Incentive Opportunity (Part of the Performance Compensation Framework)

Component	Detail
Base Salary	$645,000
Target Incentive	$516,000
Actual Payout	$654,215
Performance Metrics	Corporate Revenue with thresholds: $115.1M (threshold), $121.1M (target), $130.2M (max)

*Note: The performance compensation is calculated based on both corporate financial and strategic objectives with detailed achievement percentages and a target payout mechanism that results in an overall actual payout of $654,215 for fiscal year 2024. *